Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine-Reference-Cited by-同舟云学术

Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine

Published:2017-05-06 Issue:5 Volume:18 Page:995
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Capper David,von Deimling Andreas,Brandes Alba,Carpentier Antoine,Kesari Santosh,Sepulveda-Sanchez Juan,Wheeler Helen,Chinot Olivier,Cher Lawrence,Steinbach Joachim,Specenier Pol,Rodon Jordi,Cleverly Ann,Smith Claire,Gueorguieva Ivelina,Miles Colin,Guba Susan,Desaiah Durisala,Estrem Shawn,Lahn Michael,Wick Wolfgang

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/5/995/pdf

Reference32 articles.

1. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

2. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas;Brat;N. Engl. J. Med.,2015

3. The 2007 WHO Classification of Tumours of the Central Nervous System

4. Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies

5. Sublethal irradiation promotes migration and invasiveness of glioma cells: Implications for radiotherapy of human glioblastoma;Wild-Bode;Cancer Res.,2001

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dissecting TGF-β-induced glioblastoma invasion with engineered hyaluronic acid hydrogels;APL Bioengineering;2024-06-01

2. Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA;Cancer Gene Therapy;2023-11-21

3. Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications;Advances in Cancer Biology - Metastasis;2023-10

4. Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update;Current Oncology;2023-09-15

5. The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma;Cancers;2023-07-23